GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,398,000 | +86.9% | 20,528 | -12.3% | 0.09% | +127.5% |
| Q2 2022 | $748,000 | +10.3% | 23,397 | +19.5% | 0.04% | +11.1% |
| Q1 2022 | $678,000 | -4.2% | 19,585 | -19.0% | 0.04% | -16.3% |
| Q4 2021 | $708,000 | +185.5% | 24,183 | +148.7% | 0.04% | +207.1% |
| Q3 2021 | $248,000 | -61.2% | 9,725 | -46.7% | 0.01% | -58.8% |
| Q2 2021 | $639,000 | -0.8% | 18,237 | +15.4% | 0.03% | -8.1% |
| Q1 2021 | $644,000 | -37.7% | 15,803 | -15.7% | 0.04% | +8.8% |
| Q3 2020 | $1,034,000 | – | 18,750 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |